Evidence map›Paper›PMID 34448898›Full record

ArticleApplied microbiology and biotechnology2021

Highly tunable TetR-dependent target gene expression in the acetic acid bacterium Gluconobacter oxydans.

Philipp Moritz Fricke, Martha Lürkens, Max Hünnefeld, Christiane K Sonntag, Michael Bott, Mehdi D Davari, Tino Polen

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Applied microbiology and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Microbiology spectrum · 2023
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Philipp Moritz FrickeForschungszentrum Jülich GmbH, IBG-1: Biotechnology, Institute of Bio- and Geosciences, 52425, Jülich, Germany.ORCID http://orcid.org/0000-0002-3507-4881
Martha LürkensRWTH Aachen University, Institute of Biotechnology, Worringerweg 3, 52074, Aachen, Germany.ORCID http://orcid.org/0000-0002-6198-8767
Max HünnefeldForschungszentrum Jülich GmbH, IBG-1: Biotechnology, Institute of Bio- and Geosciences, 52425, Jülich, Germany.ORCID http://orcid.org/0000-0001-8707-6232
Christiane K SonntagForschungszentrum Jülich GmbH, IBG-1: Biotechnology, Institute of Bio- and Geosciences, 52425, Jülich, Germany.ORCID http://orcid.org/0000-0003-3764-227X
Michael BottForschungszentrum Jülich GmbH, IBG-1: Biotechnology, Institute of Bio- and Geosciences, 52425, Jülich, Germany.ORCID http://orcid.org/0000-0002-4701-8254
Mehdi D DavariDepartment of Bioorganic Chemistry, Leibniz Institute of Plant Biochemistry, Weinberg 3, 06120, Halle, Germany.ORCID http://orcid.org/0000-0003-0089-7156
Tino PolenForschungszentrum Jülich GmbH, IBG-1: Biotechnology, Institute of Bio- and Geosciences, 52425, Jülich, Germany. t.polen@fz-juelich.de.ORCID http://orcid.org/0000-0002-0065-3007
Forschungszentrum Jülich · DELeibniz Institute of Plant Biochemistry · DERWTH Aachen University · DE

Funding

bundesministerium für bildung und forschung 031B0370B
6 · The paper itself

Abstract

For the acetic acid bacterium (AAB) Gluconobacter oxydans only recently the first tight system for regulatable target gene expression became available based on the heterologous repressor-activator protein AraC from Escherichia coli and the target promoter P

Indexed as

GluconobacterGluconobacter oxydansAcetic AcidGene ExpressionPlasmidsAcetic AcidExpressionInductionMembrane-bound dehydrogenasemNeonGreenPlasmidPromoter

Identifiers

PMID34448898
PMCPMC8426231
OpenAlexW3194387578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.